KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Shares Outstanding (2016 - 2026)

Medpace Holdings filings provide 12 years of Shares Outstanding readings, the most recent being $28.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 4.28% to $28.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.6 million, a 4.28% decrease, with the full-year FY2025 number at $28.4 million, down 7.38% from a year prior.
  • Shares Outstanding hit $28.6 million in Q1 2026 for Medpace Holdings, up from $28.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $33.7 million in Q1 2022 to a low of $28.1 million in Q2 2025.
  • Median Shares Outstanding over the past 5 years was $30.7 million (2023), compared with a mean of $30.4 million.
  • Biggest five-year swings in Shares Outstanding: decreased 13.65% in 2022 and later rose 1.44% in 2024.
  • Medpace Holdings' Shares Outstanding stood at $31.1 million in 2022, then decreased by 1.09% to $30.8 million in 2023, then dropped by 0.4% to $30.6 million in 2024, then decreased by 7.38% to $28.4 million in 2025, then rose by 0.67% to $28.6 million in 2026.
  • The last three reported values for Shares Outstanding were $28.6 million (Q1 2026), $28.4 million (Q4 2025), and $28.2 million (Q3 2025) per Business Quant data.